Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® S 12,5
Ingredient(s) : Methacrylic Acid Copolymer Type B
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Copolymer Type B
Category : Controlled & Modified Release
Brand : EUDRAGIT® S 100
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® S 12,5
Grade : Oral
LOOKING FOR A SUPPLIER?